Laurens van der Flier – Startup Investor Profile

Laurens van der Flier is an Investor and VC Business Analyst at Aglaia BioMedical Ventures with a current investing position at Aglaia BioMedical Ventures as an Analyst. Laurens focuses on a diverse investment range from Seed Pharmaceuticals to Series A investments, with a sweet spot of $1.5M. Some of Laurens’ recent investments include Seed Pharmaceuticals and other investment areas alongside co-investors Karl Rothweiler, Mark Krul, Marlies Laros, and Sanne Weijzen. Laurens has a strong track record and professional career, having held positions like Managing Director Research at Prinses Máxima Centrum voor Kinderoncologie and Chief Scientific Officer at SomantiX BV. Laurens holds a Ph.D. in Molecular Genetics and a Master’s in Biomedical Sciences from Utrecht University.

Location: Netherlands

Country: Netherlands

Investment Regions: EU

Investment Stages: pre-seed, seed

Website: https://www.aglaia-oncology.com/team/

AI Reasoning: Searches for Laurens van der Flier investment activity (Aglaia team page and news) did not reveal a dated recent investment tied to Laurens (e.g., an investee such as SEED Therapeutics had a Series A-3 on Sep 23, 2025 but no listing of Laurens as participant). The Aglaia team page lists Laurens but provides no dated deal activity to determine recency. No verifiable source found that attributes a specific recent investment and date to Laurens van der Flier, so unable to determine last investment date.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.